The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning

NCT00566735 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Major Depression
Bipolar Depression
Schizoaffective Disorder

Interventions

DRUG: Razadyne
DRUG: Placebo

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]